معرفی
Beatrice Nardone, MD, PhD, serves as a Research Associate Professor in Dermatology at Northwestern University's Feinberg School of Medicine, with dual affiliation in Medicine (General Internal Medicine). Her work bridges pharmacovigilance, dermatology, and real-world data analytics through key institutional memberships including the Institute for Public Health and Medicine (IPHAM) and Northwestern University Clinical and Translational Sciences Institute (NUCATS).
- MD: University of Catania (2003)
- PhD: University of Catania (2011)
- Certificate in Pharmacoepidemiology: University of Illinois at Chicago (2019)
- Residency: Dermatology, University of Catania (2007)
Dr. Nardone's research centers on pharmacovigilance and detection of previously undetected drug adverse events using real-world data sources. As a senior researcher with the RADAR (Research on Adverse Drug events And Reports) program, she leverages FDA databases, electronic health records, and national registries to identify safety signals in dermatology. Her methodology integrates advanced non-invasive instrumentation including dermoscopy, capillaroscopy, and confocal reflectance microscopy to enhance diagnostic capabilities. Current work analyzes drug-disease interactions across diverse populations, particularly examining associations between medications (JAK inhibitors, antihypertensives, biologics) and skin cancer, cardiovascular events, and immune-mediated disorders.
Analysis of her 15 most recent publications reveals dominant themes in dermatological pharmacovigilance, with strong emphasis on population-based cancer epidemiology using SEER data, machine learning applications for patient stratification in melanoma, and rigorous safety assessments of dermatological therapeutics. Key trends include growing utilization of real-world evidence from FDA Adverse Event Reporting System (FAERS), increasing focus on site-specific cancer outcomes (acral melanoma, vulvar cancer), and methodological innovations in risk modeling for post-transplant malignancies.
Her scientific contributions demonstrate consistent application of pharmacovigilance frameworks to dermatological practice, with particular expertise in signal detection for drug-induced skin cancers, cardiovascular complications, and immune-mediated adverse events. Recent work has established methodological standards for analyzing rare adverse events in large databases.
Dr. Nardone maintains active involvement in clinical research mentoring through Northwestern's Area of Scholarly Concentration (AOSC) program, where medical students present findings at events like Lewis Landsberg Research Day. Her work frequently utilizes large Midwestern US patient populations to generate real-world evidence, with emphasis on chronic disease management and therapeutic safety monitoring.
As a RADAR program senior researcher, she directs studies examining drug-disease interactions using integrated data systems. Current initiatives focus on cardiovascular risk assessment in inflammatory skin conditions and machine learning applications for melanoma patient stratification, with implications for personalized treatment approaches in dermatology.
